Form 4 for FENC FENNEC PHARMACEUTICALS INC.
Accepted 2023-05-19 00:00:00 ET · period of report 2023-05-19 · accession 0001415889-23-008417 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-05-19 | 2023-05-19 | FENC | RALLIS CHRIS A | Dir | S - Sale | $7.36 | -1,758 | 31.0K | -5% | -$12.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2023-05-19 | S | D | 833 | $7.36 | 31,958 | D | — | — | (F1) Sale of common shares sold in accordance with 10b5-1 plan. Commom shares resulted from exercise of option grant with grant date of 4/4/2012. |
| 2 | Common | Common Shares | 2023-05-19 | S | D | 925 | $7.36 | 31,033 | D | — | — | (F2) Sale of common shares sold in accordance with 10b5-1 plan. Commom shares resulted from exercise of option grant with grant date of 5/17/2012. |